Immediate Impact

3 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
2025 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
2 intermediate papers

Works of M. Dianne Murphy being referenced

Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program
2007
Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
M. Dianne Murphy 415 226 64 70 19 630
Debbie Avant 477 169 54 89 15 590
Angelo L T Ilersich 180 108 30 115 14 702
Agnès Saint-Raymond 400 177 37 97 47 732
Anne Zajicek 274 50 73 51 29 734
Gary Tataronis 80 99 48 57 24 733
Murray Lumpkin 122 221 54 34 27 736
Sarah‐Jo Sinnott 81 137 25 83 31 528
Yeruk Mulugeta 358 70 51 20 19 576
Alessandra Atzei 365 47 80 71 16 548
Linda Tahaineh 119 71 20 87 32 536

All Works

Loading papers...

Rankless by CCL
2026